LPL Financial
ELDN icon

LPL Financial’s Eledon Pharmaceuticals ELDN Stock Holding History

LPL Financial’s Portfolio ELDN Stock Details ELDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$440K Buy
111,695
+36,735
+49% +$134K ﹤0.01% 5127
2026
Q1 		$231K Buy
74,960
+57,500
+329% +$135K ﹤0.01% 5390
2025
Q4 		$26.4K Buy
17,460
+3,810
+28% +$9.06K ﹤0.01% 5785
2025
Q3 		$35.4K Buy
+13,650
New +$39.9K ﹤0.01% 5680

Other funds holding ELDN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
Triumph Capital Management Denver, Colorado $552M AUM 20.75% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
PAM
Prodigy Asset Management Omaha, Nebraska $332M AUM 10.57% 1-Year Est. Return
DSC
Daytona Street Capital Saint Louis, Missouri $137M AUM
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
PNFS
PW Nova Financial Services Newtown, Pennsylvania $466M AUM
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

LPL Financial's ELDN Position: Q2 2026 in Review

LPL Financial increased its Eledon Pharmaceuticals (ELDN) stake by 49% in Q2 2026, buying an estimated $134K and bringing the position to 111,695 shares worth $440K. The position accounts for ﹤0.01% of the portfolio, ranked #5127.

LPL Financial first reported a position in ELDN in Q3 2025 and has held it in 4 quarters since. 62 funds tracked by Wall St. Rank hold ELDN as of Q2 2026.

  • LPL Financial held 111,695 shares of Eledon Pharmaceuticals worth $440K as of Q2 2026.
  • LPL Financial bought 36,735 Eledon Pharmaceuticals shares in Q2 2026, an estimated $134K.
  • Eledon Pharmaceuticals made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #5127 holding.
  • LPL Financial first reported a position in Eledon Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 62 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.